Cargando…
COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies
Coronavirus disease 2019 (COVID-19), which reported in an outbreak in 2019 in Wuhan, Hubei province, China, is caused by the SARS-CoV-2 virus. The virus belongs to the beta-coronavirus class, along with the Middle East Respiratory Syndrome coronavirus and Severe Acute Respiratory Syndrome coronaviru...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662254/ https://www.ncbi.nlm.nih.gov/pubmed/33158234 http://dx.doi.org/10.3390/ijerph17218155 |
_version_ | 1783609357184794624 |
---|---|
author | Rauf, Abdur Abu-Izneid, Tareq Olatunde, Ahmed Ahmed Khalil, Anees Alhumaydhi, Fahad A. Tufail, Tabussam Shariati, Mohammad Ali Rebezov, Maksim Almarhoon, Zainab M. Mabkhot, Yahia N. Alsayari, Abdulrhman Rengasamy, Kannan R. R. |
author_facet | Rauf, Abdur Abu-Izneid, Tareq Olatunde, Ahmed Ahmed Khalil, Anees Alhumaydhi, Fahad A. Tufail, Tabussam Shariati, Mohammad Ali Rebezov, Maksim Almarhoon, Zainab M. Mabkhot, Yahia N. Alsayari, Abdulrhman Rengasamy, Kannan R. R. |
author_sort | Rauf, Abdur |
collection | PubMed |
description | Coronavirus disease 2019 (COVID-19), which reported in an outbreak in 2019 in Wuhan, Hubei province, China, is caused by the SARS-CoV-2 virus. The virus belongs to the beta-coronavirus class, along with the Middle East Respiratory Syndrome coronavirus and Severe Acute Respiratory Syndrome coronavirus. Interestingly, the virus binds with angiotensin-converting enzyme-2 found in host cells, through the spike (S) protein that exists on its surface. This binding causes the entry of the virus into cells of the host organism. The actual mechanism used by the COVID-19 virus to induce disease is still speculative. A total of 44,322,504 cases, a 1,173,189 death toll and 32,486,703 recovery cases have been reported in 217 countries globally as of 28 October 2020. Symptoms from the infection of the virus include chest pain, fever, fatigue, nausea, and others. Acute respiratory stress syndrome, arrhythmia, and shock are some of the chronic manifestations recorded in severe COVID-19. Transmission is majorly by individual-to-individual through coughing, sneezing, etc. The lack of knowledge regarding the mechanism of and immune response to the virus has posed a challenge in the development of a novel drug and vaccine. Currently, treatment of the disease involves the use of anti-viral medications such as lopinavir, remdesivir, and other drugs. These drugs show some efficacy in the management of COVID-19. Studies are still on-going for the development of an ideal and novel drug for treatment. In terms of natural product intervention, Traditional Chinese Medicines (TCM) have been employed to alleviate the clinical manifestation and severity of the disease and have shown some efficacy. This review presents an updated detailed overview of COVID-19 and the virus, concerning its structure, epidemiology, symptoms and transmission, immune responses, and current interventions, and highlights the potential of TCM. It is anticipated that this review will further add to the understanding of COVID-19 and the virus, hence opening new research perspectives. |
format | Online Article Text |
id | pubmed-7662254 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-76622542020-11-14 COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies Rauf, Abdur Abu-Izneid, Tareq Olatunde, Ahmed Ahmed Khalil, Anees Alhumaydhi, Fahad A. Tufail, Tabussam Shariati, Mohammad Ali Rebezov, Maksim Almarhoon, Zainab M. Mabkhot, Yahia N. Alsayari, Abdulrhman Rengasamy, Kannan R. R. Int J Environ Res Public Health Review Coronavirus disease 2019 (COVID-19), which reported in an outbreak in 2019 in Wuhan, Hubei province, China, is caused by the SARS-CoV-2 virus. The virus belongs to the beta-coronavirus class, along with the Middle East Respiratory Syndrome coronavirus and Severe Acute Respiratory Syndrome coronavirus. Interestingly, the virus binds with angiotensin-converting enzyme-2 found in host cells, through the spike (S) protein that exists on its surface. This binding causes the entry of the virus into cells of the host organism. The actual mechanism used by the COVID-19 virus to induce disease is still speculative. A total of 44,322,504 cases, a 1,173,189 death toll and 32,486,703 recovery cases have been reported in 217 countries globally as of 28 October 2020. Symptoms from the infection of the virus include chest pain, fever, fatigue, nausea, and others. Acute respiratory stress syndrome, arrhythmia, and shock are some of the chronic manifestations recorded in severe COVID-19. Transmission is majorly by individual-to-individual through coughing, sneezing, etc. The lack of knowledge regarding the mechanism of and immune response to the virus has posed a challenge in the development of a novel drug and vaccine. Currently, treatment of the disease involves the use of anti-viral medications such as lopinavir, remdesivir, and other drugs. These drugs show some efficacy in the management of COVID-19. Studies are still on-going for the development of an ideal and novel drug for treatment. In terms of natural product intervention, Traditional Chinese Medicines (TCM) have been employed to alleviate the clinical manifestation and severity of the disease and have shown some efficacy. This review presents an updated detailed overview of COVID-19 and the virus, concerning its structure, epidemiology, symptoms and transmission, immune responses, and current interventions, and highlights the potential of TCM. It is anticipated that this review will further add to the understanding of COVID-19 and the virus, hence opening new research perspectives. MDPI 2020-11-04 2020-11 /pmc/articles/PMC7662254/ /pubmed/33158234 http://dx.doi.org/10.3390/ijerph17218155 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Rauf, Abdur Abu-Izneid, Tareq Olatunde, Ahmed Ahmed Khalil, Anees Alhumaydhi, Fahad A. Tufail, Tabussam Shariati, Mohammad Ali Rebezov, Maksim Almarhoon, Zainab M. Mabkhot, Yahia N. Alsayari, Abdulrhman Rengasamy, Kannan R. R. COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies |
title | COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies |
title_full | COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies |
title_fullStr | COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies |
title_full_unstemmed | COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies |
title_short | COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies |
title_sort | covid-19 pandemic: epidemiology, etiology, conventional and non-conventional therapies |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662254/ https://www.ncbi.nlm.nih.gov/pubmed/33158234 http://dx.doi.org/10.3390/ijerph17218155 |
work_keys_str_mv | AT raufabdur covid19pandemicepidemiologyetiologyconventionalandnonconventionaltherapies AT abuizneidtareq covid19pandemicepidemiologyetiologyconventionalandnonconventionaltherapies AT olatundeahmed covid19pandemicepidemiologyetiologyconventionalandnonconventionaltherapies AT ahmedkhalilanees covid19pandemicepidemiologyetiologyconventionalandnonconventionaltherapies AT alhumaydhifahada covid19pandemicepidemiologyetiologyconventionalandnonconventionaltherapies AT tufailtabussam covid19pandemicepidemiologyetiologyconventionalandnonconventionaltherapies AT shariatimohammadali covid19pandemicepidemiologyetiologyconventionalandnonconventionaltherapies AT rebezovmaksim covid19pandemicepidemiologyetiologyconventionalandnonconventionaltherapies AT almarhoonzainabm covid19pandemicepidemiologyetiologyconventionalandnonconventionaltherapies AT mabkhotyahian covid19pandemicepidemiologyetiologyconventionalandnonconventionaltherapies AT alsayariabdulrhman covid19pandemicepidemiologyetiologyconventionalandnonconventionaltherapies AT rengasamykannanrr covid19pandemicepidemiologyetiologyconventionalandnonconventionaltherapies |